Hormone Replacement Therapy Market To Witness Growth Rapidly Due To Large Presence Of Unmet Healthcare Needs In Emerging Economies Till 2022: Grand View Research, Inc.

Global hormone replacement therapy market is expected to reach USD 28.4 billion by 2022, according to a new report by Grand View Research, Inc. Increasing geriatric and neonatal population base, growing cases of hormonal imbalances, and large presence of unmet healthcare needs in emerging economies are some vital impact rendering drivers. 
Estrogen replacement therapy dominated the market in 2015. Moreover, the rising number of women reaching the menopausal age is expected to drive the demand for these treatments over the forecast period. 

Furthermore, rise in premature births that lead to genital disorders and slower rate of growth in these neonates are anticipated to fuel the demand for growth hormone therapy. According to statistics provided by the CDC, over 15 million babies were born preterm in 2014 annually. This number is anticipated to rise over the next seven years and become a leading cause for disabilities, illnesses, arrested development, and mortality. 

North America hormone replacement therapy market share, by product, 2012-2022 (USD Million)





Browse full research report on Hormone Replacement Therapy Market: http://www.grandviewresearch.com/industry-analysis/hormone-replacement-therapy-market    
         
Further key findings from the report suggest:

  • Estrogen therapy is expected to dominate the product segment and hold over 50.0% of the market share by 2022. This growth can be attributed to the increasing focus of healthcare bodies such as the Women’s Health Initiative, The North America Menopause Society, and The British Menopause Society, on providing safe replacement therapy.
  • The parenteral route of administration is commonly used for delivery of drugs such as Nutropin, Signifor, Genotropin, and Tev-Tropin. Other routes such as pen-based delivery systems and implants are gaining popularity owing to higher patient comfort and ease-of-use. Furthermore, technological advancements in the field providing higher bioavailability of drug and needle-free administration are predicted to positively impact growth.
  • Menopause and their vasomotor symptoms are expected to be the most prevalent disease over the forecast period owing to increasing number of women approaching the menopausal age. The segment is predicted to hold about 40.0% of the market share by 2022.
  • North America, particularly the U.S. dominated the market and held about 35.0% of the total revenue in 2015. Existence of well-regulated healthcare system and presence of a large pool of target population are a few factors that promote growth. Countries such as South Africa, China, India, and Brazil are anticipated to witness lucrative growth over the forecast period, with China predicted to have the fastest growth of over 10.0%.
  • Some key companies catering to hormone replacement therapies include Pfizer, Inc., Merck Serono, Novo Nordisk, Eli Lilly, Bayer Healthcare, Mylan Laboratories, Amgen, Novartis, and Genentech. Introduction of new formulations and development of innovative drug delivery systems are expected to be a few initiatives taken by these players over the forecast period. 

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/pharmaceuticals     
                
Grand View Research has segmented the hormone replacement therapy market on the basis of product, route of administration, disease type, and region 

Hormone Replacement Therapy Market Product Outlook (Revenue, USD Million, 2012 - 2022)
  • Estrogen Replacement Therapy
  • Human Growth Hormone Replacement Therapy
  • Thyroid Replacement Therapy
  • Other
Hormone Replacement Therapy Market Route Of Administration Outlook (Revenue, USD Million, 2012 - 2022)
  • Oral
  • Parenteral
  • Transdermal
  • Other
Hormone Replacement Therapy Market Type Of Disease Outlook (Revenue, USD Million, 2012 - 2022)
  • Menopause
  • Hypothyroidism
  • Male Hypogonadism
  • Growth Hormone Deficiency
  • Other
Hormone Replacement Therapy Market Regional Outlook (Revenue, USD Million, 2012 - 2022)
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa
    • Saudi Arabia


Access Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-hormone-replacement-therapy-market    
                              
About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.


For more information: http://www.grandviewresearch.com

Comments

Post a Comment

Popular posts from this blog

The global vein illuminator market is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient satisfaction. Additionally, factors, such as the demand for technologically advanced medical equipment and the rising research and practical applications are expected to be opportunistic for the industry growth. However, the prevalence of traditional methods owing to the high costs of the vein illuminator devices is likely to hinder the growth of the market in the near future. The vein illuminator market is segmented on the basis of technology, application, end-user, and region. Based on technology, the market is further categorized into transillumination, infrared technology, and ultrasound. The near-infrared illumination technology is estimated to be the largest shareholder due to its ability to penetrate deep into the tissue, which makes it possible to visualize the vessels clearly. On the basis of application, the market is segmented into intravenous access and blood draw. The end-user segment comprises hospitals, rehabilitation facilities, blood donation camps, and academic institutions. The market for hospitals is expected to grow rapidly during the forecast period due to a surge in the demand for technologically advanced medical equipment. The market is also categorized into North America, Europe, Asia Pacific, MEA, and Latin America. Browse full research report on global Vein Illuminator Market: http://www.grandviewresearch.com/industry-analysis/vein-illuminator-market Further key findings from the study suggest: • In terms of market share, the North America vein illuminator market is expected to hold majority of the share in 2016. Factors resulting in the growth of this industry are the steady preference for highly-advanced medical devices by hospitals as well as the presence of several medical device manufacturing companies in the region. • The infrared illumination technology is estimated to lead the industry due to its deep penetration capability into thick tissues tohighlight the presence of vessels with increased clarity. Based on application, the segment for intravenous access is estimated to be the largest shareholder, followed by the blood draw segment. • The vein illuminator industry comprises several local as well as global players. Some prominent players in this industry include Accuvein, Inc., Christie Medical Holdings, Inc., Infrared Imaging Systems, Inc., Translite, LLC, and Venoscope, LLC,among others. In order to hold a major share in the industry, the companies are adopting both organic as well as inorganic strategies. The major strategies adopted by the companies are new product development, mergers, collaborations, partnerships, geographical expansions, and acquisitions. • The companies are also focusing on research and development activities in order to enhance their product portfolio. For instance, in September 2015, Accuvein, Inc., declared its 26th patent, which was issued by the United States Patent and Trademark office for their vein visualization system. Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices Grand View Research has segmented the vein illuminator market on the basis of technology, application, and end-user application: Vein Illuminator Technology Outlook (Revenue, USD Million, 2013 - 2024) • Transillumination • Infrared technology • Others Vein Illuminator Application Outlook (Revenue, USD Million, 2013 - 2024) • Intravenous access • Blood draw • Others Vein Illuminator End-user Outlook (Revenue, USD Million, 2013 - 2024) • Hospitals • Blood donation camps • Academic institutions • Others Vein Illuminator Regional Outlook (Revenue, USD Million, 2013 - 2024) • North America • Europe • Asia Pacific • Latin America • MEA Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-vein-illuminator-market About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc For more information: www.grandviewresearch.com

The global  vein illuminator market  is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient satisfaction. Additionally, factors, such as the demand for technologically advanced medical equipment and the rising research and practical applications are expected to be opportunistic for the industry growth. However, the prevalence of traditional methods owing to the high costs of the vein illuminator devices is likely to hinder the growth of the market in the near future. The vein illuminator market is segmented on the basis of technology, application, end-user, and region. Based on technology, the market is further categorized into transillumination, infrared technology, a...
Read more

Hyaluronic Acid Market Is Likely To Be Influenced By The Increase In Obesity Till 2024: Grand View Research, Inc.

Image
The global  hyaluronic acid market   is expected to reach USD 13.4 billion by 2024, according to a new report by Grand View Research. Factors such as increasing concern in population regarding chemicals, desire to get quick and evident results, and shorter recovery time are high impact-rendering drivers of this market.  The market is evolving rapidly due to the increasing adoption of aesthetic procedures in both developed and developing regions. The growing geriatric population coupled with growing awareness about antiaging products and aspiration to look healthy and young is fueling the market for all cosmetics. The efficacy and evident results of hyaluronic acid - based dermal fillers are attracting this population base.  The increase in obesity resulting in osteoarthritis and joint pain has boosted the demand for hyaluronic acid injections as treatment. In 2012, approximately 53 million people were diagnosed with osteoarthritis and it is projected that b...
Read more

Protein Purification & Isolation Market Is Predicted To Grow Swiftly Due To Increased Research In The Fields Of Biotechnology & Pharmaceuticals Till 2025: Grand View Research, Inc.

Image
The global  protein purification and isolation market  is expected to be USD 9.5 billion by 2025, based on a new report by Grand View Research, Inc. Increased funding from both public and private research organizations for research and development of structure-based drugs and technological advancements are key drivers for the market.  Demand is increasing for the development of protein purification products based on single use purification process owing to increased proteomics research and rising need to identify new protein-based ligands with high specificity. Availability of a wide range of novel resins specific for different end users is estimated to be one of the drivers increasing the adoption rate of protein purification techniques. U.S. protein purification & isolation market, by technology, 2014 - 2025 (USD Billion) Browse full research report on Protein Purification & Isolation Market: http://www.grandviewresearch.com/industry-analysi...
Read more